Legacy Wealth Asset Management LLC Has $597,000 Holdings in Encompass Health Co. (NYSE:EHC)

Legacy Wealth Asset Management LLC trimmed its stake in Encompass Health Co. (NYSE:EHC) by 3.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,468 shares of the company’s stock after selling 216 shares during the period. Legacy Wealth Asset Management LLC’s holdings in Encompass Health were worth $597,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of EHC. CIBC Asset Management Inc increased its stake in shares of Encompass Health by 3.5% in the third quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock valued at $286,000 after buying an additional 100 shares during the period. Miracle Mile Advisors LLC lifted its position in shares of Encompass Health by 3.0% in the 4th quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company’s stock worth $354,000 after purchasing an additional 112 shares during the period. V Square Quantitative Management LLC boosted its stake in shares of Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after purchasing an additional 140 shares during the last quarter. Verdence Capital Advisors LLC increased its position in shares of Encompass Health by 4.6% during the third quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company’s stock worth $355,000 after buying an additional 160 shares during the period. Finally, Mount Yale Investment Advisors LLC raised its stake in Encompass Health by 6.6% during the second quarter. Mount Yale Investment Advisors LLC now owns 2,749 shares of the company’s stock worth $236,000 after buying an additional 170 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Encompass Health Trading Up 0.3 %

NYSE EHC opened at $94.68 on Friday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $9.54 billion, a P/E ratio of 22.87, a PEG ratio of 1.09 and a beta of 0.89. The business has a fifty day simple moving average of $97.39 and a 200 day simple moving average of $93.94. Encompass Health Co. has a 12 month low of $69.76 and a 12 month high of $104.55.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period last year, the firm earned $0.86 earnings per share. The firm’s revenue was up 11.9% on a year-over-year basis. On average, analysts predict that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on EHC shares. Barclays increased their price target on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Royal Bank of Canada raised their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. UBS Group boosted their target price on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, September 25th. KeyCorp lifted their price target on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Finally, Truist Financial reissued a “buy” rating and set a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Nine analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.